| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.01B | 41.33B | 37.79B | 40.69B | 37.19B | 29.28B |
| Gross Profit | 13.59B | 13.62B | 11.65B | 11.97B | 11.04B | 7.33B |
| EBITDA | 7.05B | 6.28B | 5.05B | 5.94B | 5.68B | 2.59B |
| Net Income | 4.19B | 3.89B | 3.25B | 3.95B | 4.06B | 1.18B |
Balance Sheet | ||||||
| Total Assets | 47.21B | 47.83B | 44.08B | 40.37B | 37.75B | 34.88B |
| Cash, Cash Equivalents and Short-Term Investments | 10.54B | 10.88B | 10.23B | 7.23B | 6.91B | 5.78B |
| Total Debt | 3.60B | 4.12B | 488.47M | 600.25M | 2.90B | 4.14B |
| Total Liabilities | 12.68B | 13.39B | 7.58B | 7.03B | 10.28B | 10.06B |
| Stockholders Equity | 34.53B | 34.43B | 36.50B | 33.34B | 27.47B | 24.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.22B | 4.41B | 1.43B | 4.51B | 1.72B |
| Operating Cash Flow | 0.00 | 6.89B | 5.27B | 2.44B | 4.80B | 3.13B |
| Investing Cash Flow | 0.00 | -3.17B | -1.06B | -857.25M | -418.98M | -1.37B |
| Financing Cash Flow | 0.00 | -3.45B | -1.38B | -1.73B | -3.77B | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥46.30B | 16.81 | ― | 3.36% | 7.18% | 29.03% | |
79 Outperform | ¥422.68B | 11.25 | ― | 1.60% | -5.16% | 200.96% | |
75 Outperform | ¥473.04B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
73 Outperform | ¥138.72B | 16.04 | ― | 5.78% | -4.26% | 17.85% | |
71 Outperform | ¥57.90B | 5.45 | 8.48% | 4.59% | 1.04% | 18.43% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥3.72B | 10.35 | ― | 3.03% | 4.17% | -693.96% |